Ann Lab Med 2017; 37(2): 174-176  
Susceptibility of Ceftolozane-Tazobactam and Ceftazidime-Avibactam Against a Collection of β-Lactam-Resistant Gram-Negative Bacteria
Mark D. Gonzalez, Ph.D.1,2, Allison R. McMullen, Ph.D.1, Meghan A. Wallace, B.S.1, Matthew P. Crotty, Pharm.D.3,4, David J. Ritchie, Pharm.D.3,5, and Carey-Ann D. Burnham, Ph.D.1
Department of Pathology and Immunology1, Division of Laboratory and Genomic Medicine, Washington University School of Medicine, St. Louis, MO; Department of Laboratory Medicine2, Children’s Healthcare of Atlanta, Atlanta, GA; Pharmacy Department3, Barnes-Jewish Hospital, St. Louis, MO; Department of Pharmacy4, Methodist Dallas Medical Center, Dallas, TX; Pharmacy Practice Department5, St. Louis College of Pharmacy, St. Louis, MO, USA
Correspondence to: Mark D. Gonzalez
Department of Laboratory Medicine, Children’s Healthcare of Atlanta, 1405 Clifton Road, NE, Atlanta, GA 30322, USA
Tel: +1-404-785-2553, Fax: +1-404-785-6342 E-mail: mark.gonzalez@choa.org
Received: March 14, 2016; Revised: August 10, 2016; Accepted: November 17, 2016; Published online: March 1, 2017.
© The Korean Society for Laboratory Medicine. All rights reserved.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


This Article

e-submission

Archives

Indexed/Covered by